FDA Inspection 1239051 — The Queen's Medical Center IRB
The FDA completed an inspection of The Queen's Medical Center IRB on April 11, 2024 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Honolulu, HI (United States)
Additional Details
IRB